Cancer / Immunology
GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments
S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong site capabilities to launch new products more q...
November 21, 2022 | News
Oncoshot and Novotech Partner to Offer Cancer Data Insights
This collaborative partnership will grant exchange and insights into real-time population data between both organisations and their affiliated leading canc...
November 11, 2022 | News
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research
Lunit to present three abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping. Lunit's presentations this year will highl...
November 08, 2022 | News
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study
Summary of Study Outcomes ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met ...
November 07, 2022 | News
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris, Completed the First Patient Dose in Phase III Trial
The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...
November 07, 2022 | News
NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is announc...
November 03, 2022 | News
Australia First in-human use of OncoRes Medical's cancer imaging system successful
OncoRes Medical today announces positive data from the first in-cavity use of its Quantitative Micro-Elastography (QME) Imaging System. The study, titled&n...
November 03, 2022 | News
Exact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening Policy
If adopted, the rule would eliminate all cost to Medicare patients for a follow-up colonoscopy after a positive at-home colorectal cancer screening test. A...
November 02, 2022 | News
T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today presents interim pre-c...
October 25, 2022 | News
Irish oncology care platform announces collaboration with NCCN
The Irish-founded oncology software company, ONCOassist, today announces a new agreement with The National Comprehensive Cancer Network® (NCCN®). T...
October 18, 2022 | News
Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging
The IND application was submitted in partnership with Grand Pharmaceutical Group Limited (Grand Pharma), Telix's partner in the Greater China reg...
October 17, 2022 | News
Health Canada Approves Illuccix® for Prostate Cancer Imaging
Illuccix™ [kit for the preparation of gallium (68Ga) gozetotide injection], after radiolabeling with gallium (68Ga), is indicated for use with the po...
October 14, 2022 | News
First patient treated in Clarity's therapeutic prostate cancer trial
Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT0...
October 10, 2022 | News
United Imaging Announces Clinical System Installations at Huntsman Cancer Institute at the University of Utah
United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced that The Center for Quantitative Cancer Imaging ...
September 16, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
